This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Asia-Pacific

  1. This document, current as of May 25, 2022, provides data and information from PATH's modeling focused on the global supply and demand of autodisable (AD) syringes, which are used for COVID-19 and routine immunizations in more than 100 countries. The cmTent forecast indicates that, despite an estimated gap of 360 million AD syringes in Q 1 2022, production capacity is adequate to meet syringe demand in Q2 2022 through Q3 2023, due to the significant capacity expansions undertaken by manufacturers and slower COVID-19 vaccination uptake than targeted timelines in many countries. The AD syringe gap analysis combines maximum syringe supply capacity collected from manufacturers in Q2 2022 with estimated syringe demand from all countries known to use AD syringes globally, including demand for both COVID- 19 and non-COVID-19 immunizations. Three potential scenarios for AD syringe demand are forecasted to reflect the uncertainty in future demand; the forecast indicates adequate supply in all three scenarios.
    Published: June 2022
    Type: Resource Page
  2. A reliable supply chain is often referred to as the “backbone” of a health system. In addition to meeting the demand for drugs and medical supplies, it serves to safeguard a country’s investments in health commodities, which is particularly important as countries ramp up efforts to work toward universal health coverage.The aim of this Journey of the Pill assessment is to identify strengths and inefficiencies in the noncommunicable disease (NCD) supply chain in Vietnam. It builds on previous NCD supply chain assessments conducted in Ghana, Kenya, and Senegal. Further defining the journey of medicines will help inform the Ministry of Health and other stakeholders of future actions to strengthen commodity security for NCDs.
    Published: June 2022
    Type: Resource Page
  3. In India, PATH supports the development of user-centric digital health tools for effective data management in human milk banks across India. This fact sheet details one such intervention which records, processes, and analyzes the end-to-end process of human milk banking
    Published: May 2022
    Type: Resource Page
  4. Ashley Birkett, PhD, head of PATH’s Malaria Vaccine Initiative, talks about next steps for RTS,S and work to develop the next generation of malaria vaccines and biologics.
    Published: May 2022
    Type: Article
  5. PATH malaria experts weigh in on what it will take to accelerate elimination—and what excites them about their work.
    Published: April 2022
    Type: Article
  6. A functional and responsive pharmacovigilance system is an essential element of any health system. After a medicine gains regulatory approval and begins to be used by doctors and patients a pharmacovigilance system will monitor the drug’s safety in real world settings by trying to detect, understand, and prevent adverse drugs reactions and other drug-related problems. PATH & partners have assessed Myanmar’s current pharmacovigilance system using WHO’s criteria is provided, as are results of previous research and recommendations to improve the pharmacovigilance system based on the assessment. Data for the review was gathered from databases (e.g. PubMed, Cochrane Library), WHO, national policy documents, domestic studies, and via key informant interviews.
    Published: April 2022
    Type: Resource Page
  7. Family planning is recognized as the second-best return on investment, after education, among all targets set under the Sustainable Development Goals (SDGs). The goal of “every pregnancy a planned pregnancy” is fundamental to progress in health and economic development. To tackle issues of access, continuity of use, and exercise of choice in family planning options, PATH is working to strengthen the supply chain of FP commodities. We designed and implemented initiatives to strengthen the supply chain systems in 8 states in India. Here's an overview of these interventions.
    Published: April 2022
    Type: Resource Page
  8. The project aims to create an equitable entrepreneurial environment for digital health developers in the places where PATH works by advancing the broad use of common open-source platforms that speed uptake and ensure sustainability.
    Published: March 2022
    Type: Announcement
  9. How PATH and the Ministry of Health are building on work against Japanese encephalitis to strengthen pandemic response.
    Published: February 2022
    Type: Article
  10. PATH India with its partners embarked on a global search for innovators and entrepreneurs in the healthcare sector with the ‘PHC Tech Challenge’. We aim to contribute to the success of comprehensive primary health care program by bringing together all the relevant stakeholders to advance efforts towards improving quality, access, and affordability of primary healthcare and introducing transformative solutions/innovations that could be demonstrated and scaled.The PHC Tech Challenge was rolled out with the objective of providing a platform that brings together promising MedTech, digital health and cold chain innovations from all across the globe for sharing with key stakeholders.Our vision through this challenge is to accelerate deployment of near-ready solutions in public health settings to improve access to primary health care in India and in other low and middle-income countries.
    Published: February 2022
    Type: Resource Page
Load more